<DOC>
	<DOCNO>NCT02202499</DOCNO>
	<brief_summary>The purpose Pilot feasibility study find effect different behavioral treatment along different duration drug call varenicline , smoke behavior quit smoking . Varenicline , also know Chantix™ , FDA-approved medication show help people quit smoking .</brief_summary>
	<brief_title>Translating Extinction Research Improve Pharmacotherapy Tobacco Dependence</brief_title>
	<detailed_description>Following initial telephone screening , eligible participant schedule screening evaluation session . Following screen evaluation , participant pass medical screening meet inclusion criterion schedule first assessment randomize receive standard varenicline ( SV ) , extend varenicline ( EV ) , extend varenicline plus facilitated extinction ( EV + FE ) . The randomization list generate study statistician . It stratify gender employ variable block randomization guarantee arm balance give block fill .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>≥18 year age Smoke least 10 cigarette daily past year Expiredair carbon monoxide ( CO ) &gt; 8 ppm Medically eligible receive varenicline Score least 5 Contemplation Ladder ( Biener &amp; Abrams 1991 ) , measure motivation quit smoking . Are pregnant lactate Have renal dysfunction Have history seizure Are medically risk judgment study physician Have ever use varenicline Have use smoking cessation medication within past three month Have current psychiatric disorder ( i.e . major depression , bipolar , and/or psychotic disorder ) Have substance use disorder determine psychiatric screener ( Mini International Neuropsychiatric Interview [ MINI ] ; Sheehan et al 2015 ) . We must limit number participant street address 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pharmacotherapy</keyword>
</DOC>